IP Library Granted Patent US 9,458,479
Granted Patent B2
US 9,458,479 · App. 14/860,103 · Granted Oct 4, 2016

Method for late introduction of the (

Inventors: Craig Arthur Townsend (Baltimore, MD); Micah Jeffrey Bodner (Dexter, OR); Ryan Martin Phelan (Emeryville, CA); Michael Francis Freeman (Bonn, DE)
Assignee: THE JOHNS HOPKINS UNIVERSITY
C12P17/10C07D477/20C12P17/184
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,458,479
App. No.
14/860,103
Granted
Oct 4, 2016
Kind
B2
Abstract

The presently disclosed subject matter demonstrates that ThnG and ThnQ enzymes encoded by the thienamycin gene cluster in Streptomyces cattleya oxidize the C-2 and C-6 moieties of carbapenems, respectively. ThnQ stereospecifically hydroxylates PS-5 giving N-acetyl thienamycin. ThnG catalyzes sequential desaturation and sulfoxidation of PS-5, giving PS-7 and its sulfoxide. The ThnG and ThnQ enzymes are relatively substrate selective, but give rise to the oxidative diversity of carbapenems produced by S. cattleya , and orthologues likely function similarly in allied streptomyces.

Claims (19)

1. A process for preparing a carbapenem of Formula (II):

the process comprising contacting or incubating a carbapenem substrate of Formula (IIa):

with a ThnG enzyme under reaction conditions to produce the carbapenem of Formula (II);

wherein:

R 1 is H;

R 4 is selected from the group consisting of, —NH-glycyl, —NH-beta-alanyl, —NHC(═O)CH 2 CH 2 CH 2 NH 2 , —NH-pantethienic acid amide, an acyl group comprising C 1 -C 10 substituted or unsubstituted linear or branched alkyl, which can further comprise one or more 3-6 member cycloalkyl rings; and

R 3 is H.

2. The process of claim 1 , wherein R 4 is selected from the group consisting of 2-hydroxyacetyl, 2-methoxyacetyl, 3-hydroxypropionyl, 4-hydroxybutanoyl, and 3,4-dihydroxybutanoyl.

3. The process of claim 1 , wherein the carbapenem of Formula (II) is:

4. A process for preparing a carbapenem of Formula (III):

the process comprising contacting or incubating a carbapenem substrate of Formula (IIIa):

with a ThnG enzyme under reaction conditions to produce a carbapenem of Formula (IIIb):

then contacting or incubating the carbapenem of Formula (IIIb) with a ThnG enzyme under reaction conditions to produce a carbapenem of Formula (III);

wherein:

R 1 is H;

R 4 is selected from the group consisting of —NH-glycyl, —NH-beta-alanyl, —NHC(═O)CH 2 CH 2 CH 2 NH 2 , —NH-pantethenic acid amide, an acyl group comprising C 1 -C 10 substituted or unsubstituted linear or branched alkyl, which can further comprise one or more 3-6 member cycloalkyl rings; and

R 3 is H.

5. The process of claim 4 , wherein R 4 is selected from the group consisting of 2-hydroxyacetyl, 2-methoxyacetyl, 3-hydroxypropionyl, 4-hydroxybutanoyl, and 3,4-dihydroxybutanoyl.

6. The process of claim 4 , wherein the carbapenem of Formula (III) is:

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 25, 2018
From: JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045147/0473 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2016
From: TOWNSEND, CRAIG ARTHUR; BODNER, MICAH JEFFREY; PHELAN, RYAN MARTIN; FREEMAN, MICHAEL FRANCIS
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 039496/0417 →
Continuity (3)
Division 13515114
Provisional Application 61285608 · Dec 11, 2009
Related Publication 20160083760A1 · Mar 24, 2016